TY - JOUR
T1 - Knowledge and adherence to SEGO recommendations for the prevention of cervical cancer by Spanish gynecologists in daily practice
AU - Cortés Bordoy, Javier
AU - Xercavins, Jordi
AU - Garrido, Rogelio
AU - Miranda, Pilar
AU - Ramón y Cajal, José Manuel
AU - Velasco, Julio
AU - Dexeus, Demián
AU - Álvarezy, Elena
AU - Centeno, Cristina
AU - Blasco Zapater, María Pilar
AU - Olives, Margarita Burgues
AU - Sánchez, María Cáceres
AU - Castro Lezcano, Alfonso de
AU - Río Castrillo, M. Pilar Del
AU - Gubert, Inmaculada Ibars
AU - Mercè Roselló, Hanna Mohamad Darwich
AU - Córdova, Melba Torres
AU - Morán, Vicenta Turrado
AU - Monera, Manuela Amorós
AU - Arroyuelo, Stella Maris
AU - Florián, Virginia Borobio
AU - Amat, Esteve Cañas
AU - Lucena, Francisco Capell
AU - Molina, Cristina García
AU - Giugni, Aldo
AU - López, Cristina Mañas
AU - Méndez Paredes, José Ramón
AU - Urruela, Xavier Planas
AU - Domingo, M. Jesús Rodríguez
AU - Puges, Maite Rovira
AU - González, Pilar Torre
AU - Gelonch, José Aixala
AU - Santacana, M. Teresa Antorn
AU - Treguany, Javier Fabregat
AU - Herrera, María Ximena
AU - Mele, Laura
AU - Peroy Pérez, José María
AU - Teixidó, Jaume Tarazona
AU - Segura, Valentí Badía
AU - Mir, Albert Canals
AU - Aparici, Montserrat Cardona
AU - García, Carlos D.Caso
AU - Raurell, Carme Castells
AU - Rodríguez, Manuel del Campo
AU - Badia, Ramon Espelti
AU - Gómez, Isabel Fernández
AU - Juanos, Jorge Leira
AU - Domínguez, Fernando Losa
AU - Juyol, Amadeu Morera
AU - Simo, Jordi Portella
AU - Blasco, Margarita Riera
AU - Mata, Raúl Villanueva
AU - Romina Castagno, Amèlia Acera Pérez
AU - Colomer, Assumpta
AU - Grau, Teresa Farguell
AU - de la Calle, Isidora Hernández
AU - Dalmases, Joan Matas
AU - Mazano, Marta Ortega
AU - Sanfeliu, Federico
AU - Espinós, Montserrat Twose
AU - Royo, Montserrat Alcalde
AU - Borell Molins, Anna Cristina
AU - Cadiñanos de Tejeiro, María del Mar
AU - Girbau, Meritxell Gispert
AU - Expósito, Verónica Márquez
AU - Enric Bosch Felip, Joan Meléndez Rusiñol
AU - de Clarke, Neomicia Cruz
AU - Román, Blanca Domenecha
AU - Garcés, Aurora Francesch
AU - Font, Yolanda Guillemat
AU - Miranda Lucas, M. José
AU - Centelles, Fernanda Pla
AU - Rodríguez Corral, Neus Luisa
AU - del Caño, Milagros Rubio
AU - Escofet, Teresa Sánchez
AU - de la Paz, Elisabet Segura
AU - Massllorens, Jordi Sentís
AU - Sales, Eva Soto
AU - Pla, Enrique Trullén
AU - Guillén, Ramón Velasco
AU - Flores, Jorge Bermúdez
AU - Compte, Gregori Borras
AU - Bernat, Eva Ciriquian
AU - Fuste, Núria
AU - Gasull, Miseriordia Guinot
AU - Aréjula, Pere Lauroba
AU - Rodríguez, Fernando Marín
AU - Clos, Carme Novoa
AU - Capdevila, Josep Palaui
AU - Radial, Guadalupe Peñalva
AU - Pérez, Alex Sanjuán
AU - Hernándezy, Juan José
AU - Ramírez, Mar
AU - Frischkorn, Alfonso Duque
AU - Alaguero, Alicia Gutiérrez
AU - Cano Cuetos, Ana Esmeralda
AU - Manrique, Ana Gómez
AU - Sánchez, Ana Pérez
AU - Guindo, Ana Román
AU - Rabanal, Antonio Rabanal
PY - 2012/1/1
Y1 - 2012/1/1
N2 - Objective: To assess the degree of knowledge of the new recommendations of the Spanish Society of Obstetrics and Gynecology (Sociedad Española de Ginecología y Obstetricia [SEGO]) for the prevention of cervical cancer and vaccination against human papilloma virus (HPV) among Spanish gynecologists and implementation of these recommendations in daily clinical practice. Methods: A cross-sectional survey (from November 2010 to March 2011) was carried out, in which participants used an online platform to complete a questionnaire previously developed by the National Scientific Committee on knowledge of the epidemiology of HPV infection, cervical cancer screening and HPV vaccines, and activities related to these issues in daily clinical practice. Results: A total of 454 gynecologists participated in the study. The gynecologists showed good knowledge of HPV transmission, HPV disease load, mortality due to cervical cancer, demonstration of immune memory, safety and efficiency of HPV vaccines, and the spectrum of protection by the tetravalent vaccine. Knowledge of the rate of sexually-active HPV-positive women at 5 years, differences between the efficacy and efficiency of cytological screening, and safe screening intervals in women with a double negative test (cytology and HPV) was deficient. Proactive attitudes to HPV vaccination in the priority age group (<27 years) was poor, with 63% of the surveyed physicians recommending vaccination. Surprisingly, 4% recommended vaccination in women older than 45 years. Fifteen percent reported they lacked time to explain that cytological testing every 3 years was safe, and 27% considered this practice unsafe. Thirty-five percent reported that the HPV test was unavailable in his/her environment. In 12% of cases, colposcopy was used to complement cytology at the initial visit. Conclusions: Although knowledge of HPV epidemiology and vaccines was adequate, proactive attitudes to HPV vaccination in the preferential age group were scarce. Complete adherence to SEGO recommendations was found in only 38% of participants. Nationwide strategies should be designed and introduced to spread and improve the implementation of these recommendations in daily clinical practice. © 2012 SEGO.
AB - Objective: To assess the degree of knowledge of the new recommendations of the Spanish Society of Obstetrics and Gynecology (Sociedad Española de Ginecología y Obstetricia [SEGO]) for the prevention of cervical cancer and vaccination against human papilloma virus (HPV) among Spanish gynecologists and implementation of these recommendations in daily clinical practice. Methods: A cross-sectional survey (from November 2010 to March 2011) was carried out, in which participants used an online platform to complete a questionnaire previously developed by the National Scientific Committee on knowledge of the epidemiology of HPV infection, cervical cancer screening and HPV vaccines, and activities related to these issues in daily clinical practice. Results: A total of 454 gynecologists participated in the study. The gynecologists showed good knowledge of HPV transmission, HPV disease load, mortality due to cervical cancer, demonstration of immune memory, safety and efficiency of HPV vaccines, and the spectrum of protection by the tetravalent vaccine. Knowledge of the rate of sexually-active HPV-positive women at 5 years, differences between the efficacy and efficiency of cytological screening, and safe screening intervals in women with a double negative test (cytology and HPV) was deficient. Proactive attitudes to HPV vaccination in the priority age group (<27 years) was poor, with 63% of the surveyed physicians recommending vaccination. Surprisingly, 4% recommended vaccination in women older than 45 years. Fifteen percent reported they lacked time to explain that cytological testing every 3 years was safe, and 27% considered this practice unsafe. Thirty-five percent reported that the HPV test was unavailable in his/her environment. In 12% of cases, colposcopy was used to complement cytology at the initial visit. Conclusions: Although knowledge of HPV epidemiology and vaccines was adequate, proactive attitudes to HPV vaccination in the preferential age group were scarce. Complete adherence to SEGO recommendations was found in only 38% of participants. Nationwide strategies should be designed and introduced to spread and improve the implementation of these recommendations in daily clinical practice. © 2012 SEGO.
KW - Cancer of the cervix
KW - Human papillomavirus
KW - Screening
KW - SEGO recommendations
U2 - 10.1016/j.pog.2012.02.001
DO - 10.1016/j.pog.2012.02.001
M3 - Article
VL - 55
SP - 153
EP - 164
IS - 4
ER -
